Marc Frahm, Ph.D.

Director, Health Care - Biotechnology

Headshot photo of Marc Frahm

Prior to joining Cowen in July 2013, Marc Frahm was a graduate research assistant at Duke University. At Duke, he studied the T-cell response to HIV, the regulation of PD-L1 expression, and developed an in vitro diagnostic method for the differentiation of active and latent TB infections.

Dr. Frahm received a BS in biochemistry from the University of Wisconsin-Madison and his Ph.D. in molecular genetics and microbiology from Duke University. HCBiopharma

Get In Touch

Start a conversation with Marc Frahm


Explore related thought leadership, reports, coverage and insights for Marc Frahm.

Ahead of the Curve®

Trials and Triumphs of Gene Editing: A Compendium

Read More
Ahead of the Curve®

An Investor’s Guide to Bispecific Antibodies

Read More
Ahead of the Curve®

Investor’s Guide to Immuno-Oncology: Focus on Novel Targets

Read More

Research Contacts

Our Research team is led by seasoned, entrepreneurial-minded individuals who are driven by a relentless curiosity to redefine expectations.

Meet Our People
Senior businessman handshaking with young woman in the office